Latest filing published 10 Aug 2023 for Oragenics INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Charles L. Pope (board member) discloses dealings in 3 companies, chiefly Inuvo, Inc., Oragenics Inc and Scienture Holdings, Inc. We count 11 filings; the first trade dates from 16 February 2016 and the latest from 8 August 2023.
Every open-market trade on record is a purchase: 1 purchase worth €1,004, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 6 share grants and 4 option exercises.
The record was last updated on 10 August 2023 with a share grant in Oragenics Inc. The latest purchase dates back some time: it was published 3,638 days ago, on 4 November 2016. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations